Depression and Anxiety Trial, Not Yet Recruiting NCT07631247 Sponsor: Dartmouth-Hitchcock Medical Center Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT07631247
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

For the 2-Week App Pilot:

  • People who are 18 years of age or older.
  • People who are caring for someone living with dementia and who score 5 or higher on two depression screening tools called the PHQ-8 and PHQ-9.
  • People who are able to communicate in English.
  • People who have access to an Android or Apple (iOS) phone or tablet that can run the iPath app.

For Debrief Interviews:

  • Care partners who have already joined the study and completed the first round of data collection may be selected for an interview, with the trial site choosing participants to ensure a range of backgrounds, genders, app usability experiences, and racial/ethnic identities.
  • Clinicians and clinical staff whose patients were involved in the project may be invited to take part in an interview.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

Care partners:

  • People whose PHQ-8 score is lower than 5.
  • People who answer positively to question 9 of the PHQ-9 and who also screen positive for suicidal thoughts with a method, intent, or plan, or who have made a recent suicide or self-harm attempt — as assessed using a specific safety tool (the Columbia-Suicide Severity Rating Scale) and reviewed by a psychiatrist at the trial site, who then determines whether participation is appropriate.
  • People who have a diagnosed bipolar disorder or psychosis, as recorded in their medical records.
  • People who have significant cognitive impairment, as recorded in their medical records or reported during the eligibility screening process.
  • People who do not have access to an Android or Apple device.

For Debrief Interviews:

  • Care partners who were withdrawn from the 2-Week App Pilot are not eligible for the debrief interviews.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Principal Investigator: Lisa A Mistler, MD, Dartmouth-Hitchcock Health

Phone: 603-731-4422

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 January 2027

Primary endpoints

Usability of Intervention; Acceptability of Intervention; Feasibility of Intervention; Appropriateness of Intervention; Treatment access; Mental health literacy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov